Arcus Biosciences announced that Jennifer Jarrett will step down as the company’s Chief Financial and Operating Officer, effective January 11, 2019, to pursue an opportunity at a privately-held transportation and technology company. Jarrett will remain actively engaged with the company and has been appointed to Arcus’s Board of Directors commencing January 12, 2019. Jarrett and the company have also entered into a consulting agreement that will ensure a seamless transition.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.